Headquarters
2083 ASCOT DR UNIT 232, MORAGA, CA 94556-2226, US
MORAGA, CA, US
From the company
EngramBio develops peptide therapeutics that repair the synaptic connections lost in Alzheimer's disease and related dementias, built on more than a decade of original neuroscience. Its lead program is based on a peptide derived from KIBRA (CT-KIBRA) that repairs damaged synapses and reverses memory deficits in preclinical models. The company combines chemistry-aware peptide design, physics-based simulation, and human iPSC-derived neuron assays in its discovery platform.
2083 ASCOT DR UNIT 232, MORAGA, CA 94556-2226, US
Quantities, certifications, and timing.